Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques

This publication has 54 references indexed in Scilit:

• Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe−/− mice
  Atherosclerosis, 2022
• The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease
  Biomedicine & Pharmacotherapy, 2021
• Comprehensive chemical analysis of Zhenshu Tiaozhi formula and its effect on ameliorating glucolipid metabolic disorders in diabetic rats
  Biomedicine & Pharmacotherapy, 2021
• Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway
  Atherosclerosis, 2021
• Fufang-Zhenzhu-Tiaozhi capsule ameliorates rabbit’s iliac artery restenosis by regulating adiponectin signaling pathway
  Biomedicine & Pharmacotherapy, 2020
• Interleukin‐36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome
  Journal of Cellular Physiology, 2020
• An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ)
  Biomedicine & Pharmacotherapy, 2020
• Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy
  Heart Failure Reviews, 2019
• Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine
  Chinese Journal of Integrative Medicine, 2017
• Psychosocial Factors and Inflammation in the Multi-Ethnic Study of Atherosclerosis
  Archives of internal medicine (1960), 2007